APC/Cyanine7 anti-mouse Ly-6C Antibody
- 产品名称:
- APC/Cyanine7 anti-mouse Ly-6C Antibody
- 产品类别:
- 抗体
- 产品编号:
- 128025
- 产品应用:
- 128025
- Verified Reactivity
- Mouse
- Antibody Type
- Monoclonal
- Host Species
- Rat
- Immunogen
- L3 cloned CTL cells
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
- Preparation
- The antibody was purified by affinity chromatography and conjugated with APC/Cyanine7 under optimal conditions.
- Concentration
- 0.2 mg/ml
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is =0.25 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.
- Excitation Laser
- Red Laser (633 nm)
- Application Notes
Clone HK1.4 does not block the binding of clone RB6-8C58.
Additional reported applications (for relevant formats of this clone) include: in vitro activation of T cells1-3 and immunohistochemistry of frozen sections4.
- Additional Product Notes
- BioLegend is in the process of converting the name APC/Cy7 to APC/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our APC/Cyanine7 products. Please contact Technical Service if you have any questions.
- Application References
(PubMed link indicates BioLegend citation) -
- Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819. (Activ)
- Herold KC, et al. 1990. Diabetes 39:815. (Activ)
- Havran WL, et al. 1988. J. Immunol. 140:1034 (Activ)
- Flanagan K, et al. 2008. J. Immunol. 180:3874. (IHC)
- Makaroff LE, et al. 2009. P. Natl. Acad. Sci. USA 106:4799. (FC)
- Zuber J, et al. 2009. Genes Dev. 23:877. (FC) PubMed
- Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
- Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
- Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
- Product Citations
-
- Parsons M, et al. 2014. J Immunol. 192:1361. PubMed
- Sun L, et al. 2021. Cancer Cell. :. PubMed
- He J, et al. 2022. Front Immunol. 12:760138. PubMed
- Ippagunta S, et al. 2016. Proc Natl Acad Sci U S A. 113: E6162 - E6171. PubMed
- Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
- Súarez-López L, et al. 2021. iScience. 24:103406. PubMed
- Sun CP, et al. 2021. PLoS Pathog. 17:e1009758. PubMed
- Abdala-Valencia H, et al. 2014. Am J Physiol Lung Cell Mol Physiol. 307:482. PubMed
- Kim AS, et al. 2021. Cell. 184(17):4414-4429.e19. PubMed
- Heng Y, et al. 2020. Glia. . PubMed
- Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
- Devalaraja S, et al. 2020. Cell. 1098:180. PubMed
- de Mingo Pulido , et al. 2021. Immunity. 54(6):1154-1167.e7. PubMed
- ?lvaro de Mingo Pulido et al. 2018. Cancer cell. 33(1):60-74 . PubMed
- Tanner MA, et al. 2021. Am J Physiol Heart Circ Physiol. 321:H633. PubMed
- McDowell SAC, et al. 2021. Nat Cancer. 2:545. PubMed
- Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
- Royzman D, et al. 2022. Front Immunol. 13:1012647. PubMed
- Lin T, et al. 2015. PLoS One. 10: e0138335. PubMed
- Wada N, et al. 2020. Mol Metab. 37:100988. PubMed
- Motoyama S, et al. 2020. Cells. :9. PubMed
- Chan YH, et al. 2019. EMBO Mol Med. 11:e10092. PubMed
- Walker FC, et al. 2021. PLoS Pathog. 17:e1009402. PubMed
- Movita D, et al. 2015. J Virol. 89:4809. PubMed
- Devalaraja S, et al. 2020. STAR Protoc. 1:100188. PubMed
- Hou X, et al. 2022. Cell Death Dis. 13:100. PubMed
- Fujita K, et al. 2019. Proc Natl Acad Sci U S A. 116:14714. PubMed
- Yu S, et al. 2016. Mol Ther. 10.1038/mt.2016.175. PubMed
- Yin S, et al. 2016. Nat Commun. 7: 11311. PubMed
- Domingos-Pereira S, et al. 2019. Cancer Immunol Res. 7:621. PubMed
- Wang Y, et al. 2021. Cell Rep. 35:108948. PubMed
- Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
- Neupane AS, et al. 2020. Cell. 183(1):110-125.e11. PubMed
- Abdul Pari AA, et al. 2020. Cancer Res. 80:2586. PubMed
- Lim HY et al. 2018. Immunity. 49(2):326-341 . PubMed
- Guérin MV, et al. 2019. Nat Commun. 10:4131. PubMed
- Witkowski MT, et al. 2020. Cancer Cell. 37:867. PubMed
- McFarland AP, et al. 2021. Immunity. 54(6):1320-1337.e4. PubMed
- Bambouskova M, et al. 2021. Cell Reports. 34(10):108756. PubMed
- AM C, et al. 2015. Proc Natl Acad Sci U S A. 112 7557 . PubMed
- Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
- Kuhn JA, et al. 2021. Elife. 10:. PubMed
- Lin J, et al. 2021. Nat Commun. 12:5321. PubMed
- Terauchi R, et al. 2021. PLoS One. 16:e0239108. PubMed
- Wang SK, et al. 2021. JCI Insight. 6: . PubMed
- Liu X, et al. 2020. Cell Host Microbe. 28(5):683-698.e6. PubMed
- Grauel AL, et al. 2020. Nat Commun. 4.84375. PubMed
- Lee L, et al. 2016. PLoS One. 11:e0167693. PubMed
- Maisel D, et al. 2016. PLoS One. 11: 0159716. PubMed
- Sim?es FC, et al. 2020. Nat Commun. 0.875. PubMed
- Luo J et al. 2018. Immunity. 49(1):107-119 . PubMed
- Shepardson K, et al. 2016. MBio. 7: e00506-16. PubMed
- Alam Z, et al. 2020. Cell Rep. 107825:31. PubMed
- Mossadegh–Keller N, et al. 2019. Bio Protoc. 9:5. PubMed
- Mohamed E, et al. 2020. Immunity. 52(4):668-682.e7.. PubMed
- Olson B, et al. 2021. Brain Behav Immun. 97:102. PubMed
- Swanson P, et al. 2016. PLoS Pathog. 12:e1006022. PubMed
- Capuccini B, et al. 2016. Sci Rep. 6:39258. PubMed
- de Laval B, et al. 2020. Cell Stem Cell. 26(5):657-674. PubMed
- Walker MT, et al. 2021. Front. Allergy. 2:. PubMed
- Mulens-Arias V, et al. 2022. Pharmaceutics. 14:. PubMed
- Bellomo A, et al. 2020. Immunity. 53(1):127-142.e7. PubMed
- Evrard M et al. 2018. Immunity. 48(2):364-379 . PubMed
- Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
- Buerfent BC, et al. 2019. GMS Infect Dis. 7:Doc04. PubMed
- Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
- Fedele C, et al. 2021. J Exp Med. 218: . PubMed
- Nicolas-Boluda A, et al. 2021. eLife. 10:00. PubMed
- Kwok I, et al. 2020. Immunity. 53(2):303-318.e5. PubMed
- van de Garde M, et al. 2016. PLoS One. 11:e0166094. PubMed
- Baker GJ, et al. 2020. Cell Syst. 0.647222222. PubMed
- Gardner A, et al. 2022. J Immunother Cancer. 10:. PubMed
- Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
- Zhang X, et al. 2020. Glia. . PubMed
- Lynn GM, et al. 2020. Nat Biotechnol. 38:320. PubMed
- RRID
- AB_10643867 (BioLegend Cat. No. 128025) AB_10640120 (BioLegend Cat. No. 128026)
- Structure
- 14-17 kD protein (134 amino acids), member of the Ly-6 family of GPI linked protein. Ly6 family members share structure homology throughout a distinctive cystein rich protein domain that incorporates O-linked carbohydrates.
- Distribution
-
Ly-6C is expressed primarily on bone marrow myeloid populations, monocytes/macrophages, neutrophils, endothelial cells, and some T cell subsets. Ly-6C is also a marker of memory CD8+ T cells.
- Cell Type
- Endothelial cells, Macrophages, Monocytes, Neutrophils, T cells
- Biology Area
- Immunology
- Molecular Family
- CD Molecules
- Antigen References
-
1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819.
2. Cerwenka A, et al. 1998. J. Immunol. 161:97.
- Gene ID
- 17067 View all products for this Gene ID
- UniProt
- View information about Ly-6C on UniProt.org